We invite you to familiarize yourself with all the standards and protocols for the early diagnosis of the most common oncological diseases. We also recommend that you make an appointment for a medical consultation if you need a serious and in-depth diagnosis of cancer. In Spain (Valencia) You can consult with our specialists while in another country.
Clinics in Valencia are equipped with modern computer equipment (in particular, 64-slice tomographs and MRI 3 Tesla), which makes it possible to carry out a complete and detailed examination for the detection of lung cancer. In addition, some screening programs include a range of genetic tests and molecular tests that can detect a predisposition to developing cancer.
These programs are covered by private insurance policies, so if you do not have health insurance, we recommend that you do so. For private patients, the cost of the program is calculated individually, depending on age.
Colorectal Cancer Screening Program in Valencia
Colorectal cancer is the third most common cancer in men and second in women. In most cases, the disease affects people under the age of 50 years. There is evidence that colorectal cancer is due to a genetic predisposition, but at about 15%, other circumstances influence its occurrence.
The program of early diagnosis of this pathology allows timely detection of the tumor. This program involves not only oncologists, but also general surgical specialists, geneticists, endoscopists and gastroenterologists.
The diagnosis of colorectal cancer in Valencia includes the following types of examinations:
- laboratory diagnostics - genetic tests, molecular studies, etc. Their main goal is to identify the cancer process or predisposition to its onset,
- radiological diagnostics.
The clinic also conducts a study and evaluation of each case by a specially created committee.
Genetic research ranks first in importance among all diagnostic methods. Timely determination of predisposition to colorectal cancer allows you to determine the patient's risk group and launch an observation program that will allow both to quickly identify the onset of the cancer process and to act more clearly and efficiently in the future.
Cervical cancer screening and cervical cancer early detection program
According to current research data, more than 3/4 of the adult population of the Earth is in constant contact with the human papillomavirus throughout their lives.
In most cases, this virus does not cause any discomfort and does not manifest itself in any way - the infection resolves itself after a couple of months. But in some patients, the development of quite serious consequences of HPV infection is possible:
1) infection with viruses types 11 and 6 (low risk, according to the current classification) causes the formation of papillomas in the genital area,
2) infection with viruses types 16 and 18 (oncogenic types in the modern classification) leads to the initiation of a cancer process. Usually the onset of the process is asymptomatic, which makes diagnosis and treatment difficult.
In the clinics of Valencia, the diagnosis of cervical cancer is performed by two methods: using cytological studies or a Pap smear. Screening studies are carried out annually, including for the purpose of diagnosing precancerous lesions and preventing the development of cervical cancer. The screening program makes it possible to significantly reduce the risk of cancer detection in the later stages.
The human papillomavirus detection program makes it possible to detect the presence of infection with an oncogenic virus group before infection causes the development of anomalies. It should be noted here that a positive test result does not mean that cancer will definitely develop - it only indicates the presence of a risk factor.
In addition to diagnostics, specialists at Valencia clinics vaccinate children and women (aged 25-45) with a quadrivalent vaccine developed against the four main types of papillomavirus. Studies in recent years show that this vaccine is effective in preventing cancer in those at risk.
Breast Cancer Early Detection Program in Valencia (Spain)
Determining the high risk of developing breast cancer is one of the key factors that ensure the effectiveness of the prevention of this disease. Breast cancer, according to statistics, ranks second (after skin cancer) in prevalence among women. Only in Spain more than 22 thousand cases are detected annually, and the disease affects both young women 30-35 years old and the elderly - up to 80 years old. In the group of maximum risk - women 45-65 years old.
In recent years, thanks to the early detection of cancer in Spain, it has been possible to significantly reduce the number of cases of late detection of breast cancer. Improving methods of treatment and prevention also played a role - today breast cancer is detected earlier, which provides more effective treatment and increases the life expectancy of patients. It should be noted that it is the early diagnosis of cancer that is the most important factor determining the entire subsequent prognosis of the course of the disease.
Spanish clinics recommend regular screening for breast cancer in women over 35 years of age. The absence of any symptoms is not a reason for refusing screening - in the early stages, the disease often does not manifest itself.
In what cases it is necessary to undergo diagnostics?
You should contact a specialist if you notice one or more of the following signs:
- a sharp change in the shape and appearance of the breast,
- the formation of hard to the touch nodules either in the chest area or in the armpits,
- retraction of the skin on the chest,
- redness of the skin area that does not disappear for a long time,
- the appearance of bloody discharge from the nipples.
In the clinics of Valencia, patients with a suspected risk of developing breast cancer have the opportunity to participate in a genetic study. The procedure will allow to establish the presence of risk and provide more effective measures for prevention and possible treatment.
Skin Cancer Early Detection Program in Valencia (Spain)
Non-melanoma skin cancer is one of the most common forms of cancer. Researchers distinguish two main types of this disease: basal cell carcinoma, which accounts for up to 3/4 of all cases, and squamous cell carcinoma.
The incidence of non-melanoma cancer has increased in the last decade. In this regard, a program for the early detection of skin cancer in Valencia clinics was developed and implemented. The coordinators of this program are dermatologists, specialists in the field of maxillofacial surgery, plastic surgeons, oncologists and genetic scientists.
What is a dermatological complex program?
This is a series of tests aimed at identifying risk factors and detecting early manifestations of non-melanoma cancer. Among them, the most important place is occupied by a dermatological examination - dermoscopy. During dermoscopy, the specialist analyzes the parameters of the skin and identifies the affected areas, as well as benign and malignant neoplasms. Based on the results of this study, a plan for further action is being drawn up.
In the clinics of Valencia, specialists also form a detailed map of skin areas. The map is a digitized photograph of various parts of the skin (face, arms, legs, back, etc.), which are brought together and analyzed. The map makes it possible to identify skin changes and monitor their development. Such a map is unique in that it allows any dermatologist to observe the patient in dynamics, tracking changes by comparing the current skin condition with previously taken images through the Bodyscan program.
Prostate Cancer Screening Program in Valencia (Spain)
The screening program is designed to timely identify patients at high risk of developing prostate cancer, assess the situation and plan more effective therapy in each case. Prostate cancer is one of the first places in prevalence among adult men. The frequency of occurrence directly depends on age. So, after 50 years, 25% men in the prostate form cancer cells. By the age of 75-80, this figure increases to 50%.
An increase in the size of the prostate does not always signal the presence of a malignant tumor - often an increase is a symptom of benign hypertrophy. However, if such a symptom is detected, it is recommended to undergo a diagnosis to make sure that there is no serious threat. Prostate cancer is a slowly progressive disease. Among the reasons for its development, researchers call a mutation in DNA - because of it, prostate cells begin to grow uncontrollably, which leads to the formation of a tumor.
Among the factors that increase the risk of cancer, researchers identify the following:
- age over 60 years,
- dark skin,
- a diet rich in fatty foods
- heredity (the presence in the family of relatives who have been diagnosed with prostate cancer).
To reduce the risk of developing the disease, experts recommend eating a healthy diet (limiting fatty meats and cheeses), maintaining a healthy weight, and getting regular screenings.
Clinical detection of prostate cancer
Men over the age of 50 should be regularly screened for prostate cancer. If there is a family history of this disease, then the risk age drops to 40 years. Even in the absence of symptoms, it is recommended to regularly visit a specialist who will give a referral for PSA and blood tests. Early detection of neoplasms is a decisive factor for successful therapy.
The clinics of Valencia have developed a unified program for diagnosing prostate cancer in the early stages. Valencia's medical institutions are equipped with everything necessary to organize a complete examination, including genetic tests.
Program for early detection of lung cancer in Valencia (Spain)
Lung cancer is the leading cause of early death in developed countries. A key factor in its occurrence is smoking. Active smokers make up over 80% of patients diagnosed with lung cancer, but those who constantly live near smokers (exposed to the so-called passive smoking) are also at risk. The longer a person smokes, and the more cigarettes he smokes daily, the higher the risk of developing lung cancer. Interestingly, among heavy smokers who quit the habit after many years of daily smoking, the risk of developing lung cancer is relatively low.
Among other reasons that determine the occurrence of lung cancer, researchers give the main place to genetic factors.
In the clinics of Valencia, a program for early screening of lung cancer has been created. The program coordinators are specialists in the field of genetics, pneumology, oncologists and endoscopists.
The screening program includes a number of tests that allow both to detect lung cancer already at the first stage and to determine whether a person belongs to a risk group. In addition to laboratory tests, X-ray examinations are included in the program. Interestingly, as early as 2010, regular lung cancer screeners using CT scans presented results reporting a 20% reduction in mortality among patients who underwent computed tomography instead of conventional x-rays.
Placing a patient in a risk group makes it possible to subsequently conduct a more thorough monitoring of his condition and detect the disease at an early stage, when the treatment prognosis is most favorable.
Early detection of cancer in Spain, as well as diagnosis and treatment of cancer, are possible in our clinics in Valencia. You can Make an appointment in Russian. We will arrange timely qualified support for you!